Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
ReviewGenetic evidence for the involvement of lipid metabolism in Alzheimer's disease
Introduction
Alzheimer's disease (AD) is a common and devastating neurodegeneration that creates enormous social, emotional and financial burdens for sufferers, their carers and for health services. It is responsible for the majority of dementia in the elderly [1]. AD is generally a disease of old age, although there are rare early onset forms that may account for up to 1% of the total burden [2]. The major risk factors for AD susceptibility are age and family history. The prevalence of AD in western populations is around 1% at age 65 rising to 25–35% of those over 85 and without new treatments the numbers of people with AD in late life will rise as life expectancy rises [3]. AD has long been recognised to be heritable and recent estimates of heritability range from 58 to 79% [4]. The known heritability of AD has underpinned many years of genetic studies to uncover the genes that underlie the various forms of this inexorably progressive disease.
Section snippets
The genetics of AD
Why is looking for genes that contribute to the causes of AD important? Genetic analysis of the association of DNA variants with disease does not require any prior biological knowledge of the disease. So genetics can reveal the aetiology of a disease without other biological information and this is its major strength.
A variety of strategies have been used to identify genes which influence AD. In family based linkage studies family members with and without the disease are compared and it is
Genetics and lipid metabolism in AD
Epidemiological studies have shown that lipid metabolism is likely to be involved in risk for AD. There is evidence that high cholesterol levels in mid-life are correlated with later dementia, and statins, which lower cholesterol levels, may have a protective effect against the development of dementia [51]. It is therefore important in understanding the aetiology of AD that the new genetic findings should be examined in the context of their potential effects on lipid metabolism.
Conclusions and future perspectives
The power of GWAS lies in their ability to reveal genes that underlie susceptibility to disease without knowledge of the underlying biology. GWAS have been hugely productive but have as yet only detected variations in DNA that can account for a small proportion of heritability of these complex diseases [35]. Meta-analyses of multiple studies can increase the power of these studies as demonstrated in Type II diabetes where a meta-analysis of three large studies increased the numbers of
References (120)
- et al.
Am. J. Hum. Genet.
(1999) Neuron
(1991)- et al.
Trends Pharmacol. Sci.
(1991) - et al.
Neuron
(2007) - et al.
Am. J. Hum. Genet.
(2008) - et al.
Am. J. Hum. Genet.
(2009) - et al.
Am. J. Hum. Genet.
(2001) - et al.
Brain Res.
(1991) - et al.
Brain Res. Brain Res. Rev.
(1998) - et al.
J. Lipid Res.
(2004)
Neuron
Neuroscience
Exp. Neurol.
Brain Res. Rev.
J. Biol. Chem.
J. Lipid Res.
J. Biol. Chem.
Neurobiol. Aging
J. Biol. Chem.
Exp. Gerontol.
Trends Biochem. Sci.
J. Lipid Res.
J. Mol. Biol.
Neuron
J. Biol. Chem.
FEBS Lett.
Trends Biochem. Sci.
J. Biol. Chem.
Trends Neurosci.
Neurobiol. Aging
Exp. Gerontol.
Arch. Neurol.
Arch. Gen. Psychiatry
Nature
Nature
Science
Nature
Nature
Science
Am. J. Hum. Genet.
Proc. Natl. Acad. Sci. U. S. A.
Nat. Rev. Genet.
Science
Nat. Med.
Proc. Natl. Acad. Sci. U. S. A.
J. Neurochem.
J. Med. Genet.
Nature
Nature
Cited by (66)
The lysosome system is severely impaired in a cellular model of neurodegeneration induced by HSV-1 and oxidative stress
2018, Neurobiology of AgingCitation Excerpt :The present results show that HSV-1 infection and OS can induce significant defects in the functioning of the lysosome system. These findings are supported by those of several genome-wide association studies that identify polymorphisms associated with AD to affect endocytosis and lipid metabolism (Harold et al., 2009; Jones et al., 2010; Lambert et al., 2009, 2013). How the latter contribute to neurodegeneration is under intense investigation, but it is already known that some of these variations result in abnormal trafficking in the endolysosomal and autophagic networks (Cormont et al., 2003; Moreau et al., 2014).
Cholesterol and Fat Metabolism in Alzheimer's Disease
2017, Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's DiseaseCurcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy
2017, Neuroscience LettersCitation Excerpt :Several studies demonstrated that paraquat is a neurotoxicant and associated with neurodegenerative diseases, such as Alzheimer’s disease [5,35]. Amyloid precursor protein (APP), Presenilin-1 (PSI), and Presenilin-2 (PSII) genes are primarily responsible for AD progression, but their mechanisms are remained to be discovered [19]. The aberrant APP production involves in the increase inflammation and oxidative stress of neurons [16,18].
The regulatory role of lipophagy in central nervous system diseases
2023, Cell Death Discovery